Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127392322 | 12739232 | 2 | F | 20160905 | 20160916 | 20160913 | 20160923 | EXP | JP-ELI_LILLY_AND_COMPANY-JP201609001944 | ELI LILLY AND CO | 31.00 | YR | M | Y | 0.00000 | 20160923 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127392322 | 12739232 | 1 | PS | STRATTERA | ATOMOXETINE HYDROCHLORIDE | 1 | Oral | UNK | 21411 | CAPSULE | |||||||||
| 127392322 | 12739232 | 2 | SS | SOLANAX | ALPRAZOLAM | 1 | Oral | UNK UNK, TID | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127392322 | 12739232 | 1 | Attention deficit/hyperactivity disorder |
| 127392322 | 12739232 | 2 | Sleep disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127392322 | 12739232 | Anxiety | |
| 127392322 | 12739232 | Dizziness | |
| 127392322 | 12739232 | Fall | |
| 127392322 | 12739232 | Intentional product misuse | |
| 127392322 | 12739232 | Overdose | |
| 127392322 | 12739232 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |